2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Glioblastoma
2
Breast Neoplasms
2
Pleural Effusion, Malignant
1
Pinealoma
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Neuroectodermal Tumors, Primitive
1
Neoplasms, Neuroepithelial
1
Neoplasm Metastasis
1
Meningioma
1
Melanoma
1
Medulloblastoma
1
Malignant Solid Neoplasm
1
Gliosarcoma
1
Glioma, Subependymal
1
Familial ependymoma
1
Ependymoma
1
Craniopharyngioma
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Cisplatin
8
Carboplatin
8
Bevacizumab
8
Pleurodesis
7
Talc
6
Paclitaxel
6
Docetaxel
5
Povidone-Iodine
4
Doxycycline
4
Thoracoscopy
3
Taxes
3
Gemcitabine
3
Drug Therapy
3
Chest Tubes
3
aldesleukin
2
Zoledronic Acid
2
Trastuzumab
2
Thoracentesis
2
Surveys and Questionnaires
2
Sodium Chloride
2
Silver Nitrate
2
Pharmaceutical Preparations
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Interleukin-2
2
High-Energy Shock Waves
2
Fluorodeoxyglucose F18
2
Fentanyl
2
Erlotinib Hydrochloride
2
Cetuximab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pleural Effusion, Malignant
×
Verteporfin
×
Clear all
NCT02702700
2019-03-20
PDT-lipo
Centre Hospitalier Universitaire Vaudois
Phase 1
Terminated
1 enrolled